Herein, we identified a new signaling axis “BCR-ABL-TAL1-TSPAN32-PTEN-PI3K-AKT” and reveal its biological roles in BCR-ABL induced leukemias and TKI therapy. This evidence concerns the gene TAL1 and leukemia.